RALEIGH, N.C. and NEW YORK, March 9, 2021 /PRNewswire/ — Phreesia, the nation’s leading patient intake platform, is pleased to announce it has partnered with CONVINCE USA, an initiative out of the CUNY Graduate School of Public Health & Health Policy (CUNY SPH), to create a patient survey and data-driven education tool to better understand and address patients’ COVID-19 vaccine hesitancy. To date, more than 300,000 survey responses have been collected across Phreesia’s nationwide network, providing valuable insights that can enable targeted interventions to engage and inform more hesitant groups and shed light on the relationship between access and hesitancy.
For example, while 78% of respondents 65 and older reported that they were likely to get the vaccine, less than half of essential workers said they were likely to be vaccinated, according to initial survey data. Additionally, a significant number of respondents who expressed hesitancy were more likely to get the vaccine if it were recommended by their doctor.
The COVID-19 vaccine hesitancy survey has been implemented by leading health systems and federally qualified health centers, including Ascension, a faith-based national health system that serves 19 states, and HealthLinc, an FQHC with clinics across Northern Indiana.
CONVINCE USA is part of a global partnership with the Vaccine Confidence Project of the London School of Hygiene & Tropical Medicine and Wilton Park. CONVINCE USA has received funds from CDC…
